Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 322

1.

Perceptions of Patients With Chronic Obstructive Pulmonary Disease and Their Physiotherapists Regarding the Use of an eHealth Intervention.

Vorrink S, Huisman C, Kort H, Troosters T, Lammers JW.

JMIR Hum Factors. 2017 Sep 19;4(3):e20. doi: 10.2196/humanfactors.7196.

2.

Can routine chest radiography be used to diagnose mild COPD? A nested case-control study.

den Harder AM, Snoek AM, Leiner T, Suyker WJ, de Heer LM, Budde RPJ, Lammers JWJ, de Jong PA, Gondrie MJA.

Eur J Radiol. 2017 Jul;92:159-165. doi: 10.1016/j.ejrad.2017.05.007. Epub 2017 May 9.

PMID:
28624014
3.

Proteomic profiling of peripheral blood neutrophils identifies two inflammatory phenotypes in stable COPD patients.

Loi ALT, Hoonhorst S, van Aalst C, Langereis J, Kamp V, Sluis-Eising S, Ten Hacken N, Lammers JW, Koenderman L.

Respir Res. 2017 May 22;18(1):100. doi: 10.1186/s12931-017-0586-x.

4.

Improving early diagnosis of pulmonary infections in patients with febrile neutropenia using low-dose chest computed tomography.

Gerritsen MG, Willemink MJ, Pompe E, van der Bruggen T, van Rhenen A, Lammers JW, Wessels F, Sprengers RW, de Jong PA, Minnema MC.

PLoS One. 2017 Feb 24;12(2):e0172256. doi: 10.1371/journal.pone.0172256. eCollection 2017.

5.

Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis.

Hobbs BD, de Jong K, Lamontagne M, Bossé Y, Shrine N, Artigas MS, Wain LV, Hall IP, Jackson VE, Wyss AB, London SJ, North KE, Franceschini N, Strachan DP, Beaty TH, Hokanson JE, Crapo JD, Castaldi PJ, Chase RP, Bartz TM, Heckbert SR, Psaty BM, Gharib SA, Zanen P, Lammers JW, Oudkerk M, Groen HJ, Locantore N, Tal-Singer R, Rennard SI, Vestbo J, Timens W, Paré PD, Latourelle JC, Dupuis J, O'Connor GT, Wilk JB, Kim WJ, Lee MK, Oh YM, Vonk JM, de Koning HJ, Leng S, Belinsky SA, Tesfaigzi Y, Manichaikul A, Wang XQ, Rich SS, Barr RG, Sparrow D, Litonjua AA, Bakke P, Gulsvik A, Lahousse L, Brusselle GG, Stricker BH, Uitterlinden AG, Ampleford EJ, Bleecker ER, Woodruff PG, Meyers DA, Qiao D, Lomas DA, Yim JJ, Kim DK, Hawrylkiewicz I, Sliwinski P, Hardin M, Fingerlin TE, Schwartz DA, Postma DS, MacNee W, Tobin MD, Silverman EK, Boezen HM, Cho MH; COPDGene Investigators; ECLIPSE Investigators; LifeLines Investigators; SPIROMICS Research Group; International COPD Genetics Network Investigators; UK BiLEVE Investigators; International COPD Genetics Consortium.

Nat Genet. 2017 Mar;49(3):426-432. doi: 10.1038/ng.3752. Epub 2017 Feb 6.

6.

Determinants of activation for self-management in patients with COPD.

Korpershoek Y, Bos-Touwen ID, de Man-van Ginkel JM, Lammers JW, Schuurmans MJ, Trappenburg J.

Int J Chron Obstruct Pulmon Dis. 2016 Aug 1;11:1757-66. doi: 10.2147/COPD.S109016. eCollection 2016.

7.

Diffuse Idiopathic Skeletal Hyperostosis Is Associated with Lower Lung Volumes in Current and Former Smokers.

Oudkerk SF, Buckens CF, Mali WP, De Koning HJ, Öner FC, Vliegenthart R, Pompe E, Lammers JW, Mohamed Hoesein FA, Verlaan JJ, de Jong PA.

Am J Respir Crit Care Med. 2016 Jul 15;194(2):241-2. doi: 10.1164/rccm.201510-1971LE. No abstract available.

PMID:
27420360
8.

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.

Yousaf-Khan U, van der Aalst C, de Jong PA, Heuvelmans M, Scholten E, Lammers JW, van Ooijen P, Nackaerts K, Weenink C, Groen H, Vliegenthart R, Ten Haaf K, Oudkerk M, de Koning H.

Thorax. 2017 Jan;72(1):48-56. doi: 10.1136/thoraxjnl-2016-208655. Epub 2016 Jun 30.

PMID:
27364640
9.

Smokers with emphysema and small airway disease on computed tomography have lower bone density.

Pompe E, de Jong PA, van Rikxoort EM, Gallardo Estrella L, de Jong WU, Vliegenthart R, Oudkerk M, van der Aalst CM, van Ginneken B, Lammers JW, Mohamed Hoesein FA.

Int J Chron Obstruct Pulmon Dis. 2016 Jun 8;11:1207-16. doi: 10.2147/COPD.S103680. eCollection 2016.

10.

Advanced glycation endproducts and their receptor in different body compartments in COPD.

Hoonhorst SJ, Lo Tam Loi AT, Pouwels SD, Faiz A, Telenga ED, van den Berge M, Koenderman L, Lammers JW, Boezen HM, van Oosterhout AJ, Lodewijk ME, Timens W, Postma DS, Ten Hacken NH.

Respir Res. 2016 Apr 26;17:46. doi: 10.1186/s12931-016-0363-2.

11.

Pulmonary Nodule Volumetry at Different Low Computed Tomography Radiation Dose Levels With Hybrid and Model-Based Iterative Reconstruction: A Within Patient Analysis.

den Harder AM, Willemink MJ, van Hamersvelt RW, Vonken EP, Schilham AM, Lammers JW, Luijk B, Budde RP, Leiner T, de Jong PA.

J Comput Assist Tomogr. 2016 Jul-Aug;40(4):578-83. doi: 10.1097/RCT.0000000000000408.

PMID:
27096400
12.

Pleural Fluid and Tuberculosis: Are All Interferon Gamma Release Assays Equal?

Hofland RW, Bossink AW, Lammers JW, Thijsen SF.

J Clin Microbiol. 2016 Feb;54(2):504-5. doi: 10.1128/JCM.02653-15. No abstract available.

13.

A Mobile Phone App to Stimulate Daily Physical Activity in Patients with Chronic Obstructive Pulmonary Disease: Development, Feasibility, and Pilot Studies.

Vorrink SN, Kort HS, Troosters T, Lammers JW.

JMIR Mhealth Uhealth. 2016 Jan 26;4(1):e11. doi: 10.2196/mhealth.4741.

14.

Inter-observer and inter-examination variability of manual vertebral bone attenuation measurements on computed tomography.

Pompe E, de Jong PA, de Jong WU, Takx RA, Eikendal AL, Willemink MJ, Oudkerk M, Budde RP, Lammers JW, Mohamed Hoesein FA.

Eur Radiol. 2016 Sep;26(9):3046-53. doi: 10.1007/s00330-015-4145-x. Epub 2016 Jan 22.

15.

Effect of radiation dose reduction and iterative reconstruction on computer-aided detection of pulmonary nodules: Intra-individual comparison.

Den Harder AM, Willemink MJ, van Hamersvelt RW, Vonken EJ, Milles J, Schilham AM, Lammers JW, de Jong PA, Leiner T, Budde RP.

Eur J Radiol. 2016 Feb;85(2):346-51. doi: 10.1016/j.ejrad.2015.12.003. Epub 2015 Dec 7.

PMID:
26781139
16.

Pulmonary embolism due to a contraceptive vaginal ring (NuvaRing).

Krivokuca I, Lammers JW.

Vascular. 2015 Dec;23(6):639-40. doi: 10.1177/1708538115609809. Epub 2015 Oct 7. No abstract available.

PMID:
26450600
17.

Diagnostic and prognostic utility of mid-expiratory flow rate in older community-dwelling persons with respiratory symptoms, but without chronic obstructive pulmonary disease.

Güder G, Brenner S, Störk S, Held M, Broekhuizen BD, Lammers JW, Hoes AW, Rutten FH.

BMC Pulm Med. 2015 Jul 31;15:83. doi: 10.1186/s12890-015-0081-4.

18.

Incidental findings on chest CT imaging are associated with increased COPD exacerbations and mortality.

Jairam PM, van der Graaf Y, Lammers JW, Mali WP, de Jong PA; PROVIDI Study group.

Thorax. 2015 Aug;70(8):725-31. doi: 10.1136/thoraxjnl-2014-206160. Epub 2015 May 29.

PMID:
26024687
19.

Correction: Susceptibility to chronic mucus hypersecretion, a genome wide association study.

Dijkstra AE, Smolonska J, van den Berge M, Wijmenga C, Zanen P, Luinge MA, Platteel M, Lammers JW, Dahlback M, Tosh K, Hiemstra PS, Sterk PJ, Spira A, Vestbo J, Nordestgaard BG, Benn M, Nielsen SF, Dahl M, Verschuren WM, Picavet HS, Smit HA, Owsijewitsch M, Kauczor HU, de Koning HJ, Nizankowska-Mogilnicka E, Mejza F, Nastalek P, van Diemen CC, Cho MH, Silverman EK, Crapo JD, Beaty TH, Lomas DA, Bakke P, Gulsvik A, Bossé Y, Obeidat M, Loth DW, Lahousse L, Rivadeneira F, Uitterlinden AG, Hofman A, Stricker BH, Brusselle GG, van Duijn CM, Brouwer U, Koppelman GH, Vonk JM, Nawijn MC, Groen HJ, Timens W, Boezen HM, Postma DS; LifeLines Cohort Study.

PLoS One. 2015 May 29;10(5):e0129524. doi: 10.1371/journal.pone.0129524. eCollection 2015. No abstract available.

20.

Parametric response mapping adds value to current computed tomography biomarkers in diagnosing chronic obstructive pulmonary disease.

Pompe E, van Rikxoort EM, Schmidt M, Rühaak J, Estrella LG, Vliegenthart R, Oudkerk M, de Koning HJ, van Ginneken B, de Jong PA, Lammers JW, Mohamed Hoesein FA.

Am J Respir Crit Care Med. 2015 May 1;191(9):1084-6. doi: 10.1164/rccm.201411-2105LE. No abstract available.

PMID:
25932766
21.

Airway wall thickness associated with forced expiratory volume in 1 second decline and development of airflow limitation.

Mohamed Hoesein FA, de Jong PA, Lammers JW, Mali WP, Schmidt M, de Koning HJ, van der Aalst C, Oudkerk M, Vliegenthart R, Groen HJ, van Ginneken B, van Rikxoort EM, Zanen P.

Eur Respir J. 2015 Mar;45(3):644-51. doi: 10.1183/09031936.00020714. Epub 2015 Jan 22.

22.

Novel genes for airway wall thickness identified with combined genome-wide association and expression analyses.

Dijkstra AE, Postma DS, van Ginneken B, Wielpütz MO, Schmidt M, Becker N, Owsijewitsch M, Kauczor HU, de Koning HJ, Lammers JW, Oudkerk M, Brandsma CA, Bossé Y, Nickle DC, Sin DD, Hiemstra PS, Wijmenga C, Smolonska J, Zanen P, Vonk JM, van den Berge M, Boezen HM, Groen HJ.

Am J Respir Crit Care Med. 2015 Mar 1;191(5):547-56. doi: 10.1164/rccm.201405-0840OC.

PMID:
25517131
23.

The Dutch functional performance inventory: validity and reliability in patients with chronic obstructive lung disease.

Weldam SW, Lammers JW, de Bruin-Veelers MC, Schuurmans MJ.

Nurs Res. 2015 Jan-Feb;64(1):44-52. doi: 10.1097/NNR.0000000000000067.

PMID:
25502060
24.

Staged decision making was an attractive alternative to a plenary approach in panel diagnosis as reference standard.

Bertens LC, van Mourik Y, Rutten FH, Cramer MJ, Lammers JW, Hoes AW, Reitsma JB, Moons KG.

J Clin Epidemiol. 2015 Apr;68(4):418-25. doi: 10.1016/j.jclinepi.2014.09.020. Epub 2014 Nov 4.

PMID:
25459980
25.

Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules?

Scholten ET, de Jong PA, de Hoop B, van Klaveren R, van Amelsvoort-van de Vorst S, Oudkerk M, Vliegenthart R, de Koning HJ, van der Aalst CM, Vernhout RM, Groen HJ, Lammers JW, van Ginneken B, Jacobs C, Mali WP, Horeweg N, Weenink C, Thunnissen E, Prokop M, Gietema HA.

Eur Respir J. 2015 Mar;45(3):765-73. doi: 10.1183/09031936.00005914. Epub 2014 Nov 27. Erratum in: Eur Respir J. 2015 May;45(5):1517.

26.

Unrecognized heart failure and chronic obstructive pulmonary disease (COPD) in frail elderly detected through a near-home targeted screening strategy.

van Mourik Y, Bertens LC, Cramer MJ, Lammers JW, Reitsma JB, Moons KG, Hoes AW, Rutten FH.

J Am Board Fam Med. 2014 Nov-Dec;27(6):811-21. doi: 10.3122/jabfm.2014.06.140045.

27.

Increased activation of blood neutrophils after cigarette smoking in young individuals susceptible to COPD.

Hoonhorst SJ, Timens W, Koenderman L, Lo Tam Loi AT, Lammers JW, Boezen HM, van Oosterhout AJ, Postma DS, Ten Hacken NH.

Respir Res. 2014 Oct 10;15:121. doi: 10.1186/s12931-014-0121-2.

28.

Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.

Horeweg N, van Rosmalen J, Heuvelmans MA, van der Aalst CM, Vliegenthart R, Scholten ET, ten Haaf K, Nackaerts K, Lammers JW, Weenink C, Groen HJ, van Ooijen P, de Jong PA, de Bock GH, Mali W, de Koning HJ, Oudkerk M.

Lancet Oncol. 2014 Nov;15(12):1332-41. doi: 10.1016/S1470-2045(14)70389-4. Epub 2014 Oct 1.

PMID:
25282285
29.

Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.

Horeweg N, Scholten ET, de Jong PA, van der Aalst CM, Weenink C, Lammers JW, Nackaerts K, Vliegenthart R, ten Haaf K, Yousaf-Khan UA, Heuvelmans MA, Thunnissen E, Oudkerk M, Mali W, de Koning HJ.

Lancet Oncol. 2014 Nov;15(12):1342-50. doi: 10.1016/S1470-2045(14)70387-0. Epub 2014 Oct 1.

PMID:
25282284
30.

Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD.

Dijkstra AE, Boezen HM, van den Berge M, Vonk JM, Hiemstra PS, Barr RG, Burkart KM, Manichaikul A, Pottinger TD, Silverman EK, Cho MH, Crapo JD, Beaty TH, Bakke P, Gulsvik A, Lomas DA, Bossé Y, Nickle DC, Paré PD, de Koning HJ, Lammers JW, Zanen P, Smolonska J, Wijmenga C, Brandsma CA, Groen HJ, Postma DS; LifeLines Cohort Study group.

Eur Respir J. 2015 Jan;45(1):60-75. doi: 10.1183/09031936.00093314. Epub 2014 Sep 18.

31.

Pulmonary function and CT biomarkers as risk factors for cardiovascular events in male lung cancer screening participants: the NELSON study.

Takx RA, Vliegenthart R, Mohamed Hoesein FA, Išgum I, de Koning HJ, Mali WP, van der Aalst CM, Zanen P, Lammers JW, Groen HJ, van Rikxoort EM, Schmidt M, van Ginneken B, Oudkerk M, Leiner T, de Jong PA.

Eur Radiol. 2015 Jan;25(1):65-71. doi: 10.1007/s00330-014-3384-6. Epub 2014 Sep 3.

PMID:
25182625
32.

Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD.

Mohamed Hoesein FA, de Jong PA, Lammers JW, Mali WP, Mets OM, Schmidt M, de Koning HJ, Aalst Cv, Oudkerk M, Vliegenthart R, Ginneken Bv, van Rikxoort EM, Zanen P.

COPD. 2014 Sep;11(5):503-9. doi: 10.3109/15412555.2014.933952. Epub 2014 Aug 5.

PMID:
25093696
33.

Perceived quality of life in chronic obstructive pulmonary disease patients: a cross-sectional study in primary care on the role of illness perceptions.

Weldam SW, Lammers JW, Heijmans MJ, Schuurmans MJ.

BMC Fam Pract. 2014 Aug 3;15:140. doi: 10.1186/1471-2296-15-140.

34.

Advanced glycation end products in the skin are enhanced in COPD.

Hoonhorst SJ, Lo Tam Loi AT, Hartman JE, Telenga ED, van den Berge M, Koenderman L, Lammers JW, Boezen HM, Postma DS, Ten Hacken NH.

Metabolism. 2014 Sep;63(9):1149-56. doi: 10.1016/j.metabol.2014.06.006. Epub 2014 Jun 13.

PMID:
25034386
35.

Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis.

Smolonska J, Koppelman GH, Wijmenga C, Vonk JM, Zanen P, Bruinenberg M, Curjuric I, Imboden M, Thun GA, Franke L, Probst-Hensch NM, Nürnberg P, Riemersma RA, van Schayck CP, Loth DW, Brusselle GG, Stricker BH, Hofman A, Uitterlinden AG, Lahousse L, London SJ, Loehr LR, Manichaikul A, Barr RG, Donohue KM, Rich SS, Pare P, Bossé Y, Hao K, van den Berge M, Groen HJ, Lammers JW, Mali W, Boezen HM, Postma DS.

Eur Respir J. 2014 Oct;44(4):860-72. doi: 10.1183/09031936.00001914. Epub 2014 Jul 3.

36.

CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters.

Maarschalk-Ellerbroek LJ, de Jong PA, van Montfrans JM, Lammers JW, Bloem AC, Hoepelman AI, Ellerbroek PM.

J Clin Immunol. 2014 Aug;34(6):642-54. doi: 10.1007/s10875-014-0068-6. Epub 2014 Jun 21.

PMID:
24952009
37.

COPD detected with screening: impact on patient management and prognosis.

Bertens LC, Reitsma JB, van Mourik Y, Lammers JW, Moons KG, Hoes AW, Rutten FH.

Eur Respir J. 2014 Dec;44(6):1571-8. doi: 10.1183/09031936.00074614. Epub 2014 Jun 12.

38.

A patient with respiratory distress.

Krivokuca I, Lammers JW.

Emerg Med J. 2015 May;32(5):411. doi: 10.1136/emermed-2014-203829. Epub 2014 May 29. No abstract available.

PMID:
24876155
39.

Association of chronic obstructive pulmonary disease and smoking status with bone density and vertebral fractures in male lung cancer screening participants.

de Jong WU, de Jong PA, Vliegenthart R, Isgum I, Lammers JW, Oudkerk M, van der Aalst C, de Koning HJ, Mohamed Hoesein FA.

J Bone Miner Res. 2014 Oct;29(10):2224-9. doi: 10.1002/jbmr.2248.

40.

Susceptibility to chronic mucus hypersecretion, a genome wide association study.

Dijkstra AE, Smolonska J, van den Berge M, Wijmenga C, Zanen P, Luinge MA, Platteel M, Lammers JW, Dahlback M, Tosh K, Hiemstra PS, Sterk PJ, Spira A, Vestbo J, Nordestgaard BG, Benn M, Nielsen SF, Dahl M, Verschuren WM, Picavet HS, Smit HA, Owsijewitsch M, Kauczor HU, de Koning HJ, Nizankowska-Mogilnicka E, Mejza F, Nastalek P, van Diemen CC, Cho MH, Silverman EK, Crapo JD, Beaty TH, Lomas DA, Bakke P, Gulsvik A, Bossé Y, Obeidat M, Loth DW, Lahousse L, Rivadeneira F, Uitterlinden AG, Hofman A, Stricker BH, Brusselle GG, van Duijn CM, Brouwer U, Koppelman GH, Vonk JM, Nawijn MC, Groen HJ, Timens W, Boezen HM, Postma DS; LifeLines Cohort study.

PLoS One. 2014 Apr 8;9(4):e91621. doi: 10.1371/journal.pone.0091621. eCollection 2014. Erratum in: PLoS One. 2015;10(5):e0129524. Obeidat, M A [corrected to Obeidat, Ma'en].

41.

Lower corticosteroid skin blanching response is associated with severe COPD.

Hoonhorst SJ, ten Hacken NH, Lo Tam Loi AT, Koenderman L, Lammers JW, Telenga ED, Boezen HM, van den Berge M, Postma DS.

PLoS One. 2014 Mar 12;9(3):e91788. doi: 10.1371/journal.pone.0091788. eCollection 2014.

42.

[Screening for lung cancer using CT: time for implementation?].

de Jong PA, Lammers JW.

Ned Tijdschr Geneeskd. 2013;157(46):A7019. Dutch.

PMID:
24220184
43.

Daily activities and health-related quality of life in patients with chronic obstructive pulmonary disease: psychological determinants: a cross-sectional study.

Weldam SW, Lammers JW, Decates RL, Schuurmans MJ.

Health Qual Life Outcomes. 2013 Nov 5;11:190. doi: 10.1186/1477-7525-11-190.

44.

Development and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease.

Bertens LC, Reitsma JB, Moons KG, van Mourik Y, Lammers JW, Broekhuizen BD, Hoes AW, Rutten FH.

Int J Chron Obstruct Pulmon Dis. 2013;8:493-9. doi: 10.2147/COPD.S49609. Epub 2013 Oct 10.

45.

Discriminating dominant computed tomography phenotypes in smokers without or with mild COPD.

Mohamed Hoesein FA, Schmidt M, Mets OM, Gietema HA, Lammers JW, Zanen P, de Koning HJ, van der Aalst C, Oudkerk M, Vliegenthart R, Isgum I, Prokop M, van Ginneken B, van Rikxoort EM, de Jong PA.

Respir Med. 2014 Jan;108(1):136-43. doi: 10.1016/j.rmed.2013.08.014. Epub 2013 Aug 30.

46.

Clinical utility of asthma biomarkers: from bench to bedside.

Vijverberg SJ, Hilvering B, Raaijmakers JA, Lammers JW, Maitland-van der Zee AH, Koenderman L.

Biologics. 2013;7:199-210. doi: 10.2147/BTT.S29976. Epub 2013 Aug 29. Review.

47.

Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial.

Horeweg N, van der Aalst CM, Vliegenthart R, Zhao Y, Xie X, Scholten ET, Mali W, Thunnissen E, Weenink C, Groen HJ, Lammers JW, Nackaerts K, van Rosmalen J, Oudkerk M, de Koning HJ.

Eur Respir J. 2013 Dec;42(6):1659-67. doi: 10.1183/09031936.00197712. Epub 2013 Jul 11.

48.

Computed tomography structural lung changes in discordant airflow limitation.

Mohamed Hoesein FA, de Jong PA, Lammers JW, Mali WP, Schmidt M, de Koning HJ, van der Aalst C, Oudkerk M, Vliegenthart R, van Ginneken B, van Rikxoort EM, Zanen P.

PLoS One. 2013 Jun 13;8(6):e65177. doi: 10.1371/journal.pone.0065177. Print 2013.

49.

Lung cancer screening CT-based prediction of cardiovascular events.

Mets OM, Vliegenthart R, Gondrie MJ, Viergever MA, Oudkerk M, de Koning HJ, Mali WP, Prokop M, van Klaveren RJ, van der Graaf Y, Buckens CF, Zanen P, Lammers JW, Groen HJ, Isgum I, de Jong PA.

JACC Cardiovasc Imaging. 2013 Aug;6(8):899-907. doi: 10.1016/j.jcmg.2013.02.008. Epub 2013 Jun 13.

50.

Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening.

Mets OM, Schmidt M, Buckens CF, Gondrie MJ, Isgum I, Oudkerk M, Vliegenthart R, de Koning HJ, van der Aalst CM, Prokop M, Lammers JW, Zanen P, Mohamed Hoesein FA, Mali WP, van Ginneken B, van Rikxoort EM, de Jong PA.

Respir Res. 2013 May 27;14:59. doi: 10.1186/1465-9921-14-59.

Supplemental Content

Loading ...
Support Center